{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T17:14:07Z","timestamp":1773076447491,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Worldwide ranking above HIV\/AIDS, tuberculosis is continues to have a significant effect on public health and the leading cause of death due to high progression of HIV. The objective of current study was identify joint clinical determinants that affecting bivariate hematological parameter among TB\/HIV co-infected adults under TB\/HIV treatment in university of Gondar comprehensive specialized hospital.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Method<\/jats:title>\n                <jats:p>The result of these study was conducted at university of Gondar comprehensive specialized hospital, Gondar, Ethiopia by using a retrospective cohort follow up study from September 2015-march 2022 G.C. The source of data in this study was secondary data obtained from patients chart. Bayesian approach of longitudinal linear mixed effect sub model was used in panel data set to get wide range of information about TB\/HIV co-infected patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Result<\/jats:title>\n                <jats:p>Out of 148 co-infected participants more than half of the patients (56.1%) and (52.7%) accounted for CPT and INH non users, of which 10.8% and 10.3% had the outcome of mortality respectively. The random intercept and slope model were selected for repeated measure hemoglobin level and hematocrit based on deviance information criteria (DIC), and probability of direction (Pd) under the full model.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Current study revealed that clinical predictors red blood cell count, platelet cell count, fair and good treatment adherence, other ART regiment, IPT drug users, and viral load count\u2009&lt;\u200910,000 copies\/mL, were associated with high hemoglobin level concentration while, lymphocyte count, WHO clinical stage-IV,1e ART regiment, and patients with OIs results for low hemoglobin level concentration. Likewise, red blood cell count, platelet cell count, fair and good treatment adherence, IPT drug users, and viral load count\u2009&lt;\u200910,000 copies\/mL co-infected patients had high hematocrit, while lymphocyte count, WHO clinical stage-III,1c ART regiment, and patients with OIs significantly leads to low hematocrit. Health professionals give more attention to these important predictors to reduce progression of disease when the co-infected patients come back again in the hospital. In addition, health staff should conduct health related education for individuals to examine continuous check-up of co-infected patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13104-024-06808-6","type":"journal-article","created":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T09:01:38Z","timestamp":1717232498000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Joint clinical determinants for bivariate hematological parameter among TB\/HIV co-infected adults under TB\/HIV treatment in university of Gondar comprehensive specialized hospital: Retrospective panel data study"],"prefix":"10.1186","volume":"17","author":[{"given":"Nurye Seid","family":"Muhie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,1]]},"reference":[{"key":"6808_CR1","unstructured":"World Health Organization. global TUBERCLOSIS REPORT. 2022."},{"key":"6808_CR2","doi-asserted-by":"crossref","unstructured":"Mollel EW, Chilongola JO, Mpagama SG, Kibiki GS. Evaluation of XpertMTB \/ RIF performance for diagnosis of tuberculosis among HIV positive patients in northern Tanzania, 19, 1, pp. 1\u20139, 2017.","DOI":"10.4314\/thrb.v19i1.1"},{"key":"6808_CR3","unstructured":"World Health Organization. global TUBERCLOSIS REPORT. 2023."},{"key":"6808_CR4","first-page":"467","volume-title":"Survival Trend of Tuberculosis patients and risk factors Associated with Mortality and developing drug-resistant tuberculosis in Hospital Pulau Pinang","author":"AR Yaghi","year":"2022","unstructured":"Yaghi AR, Shaheed HS, Harun SN, Ali I, Ali H, Khan AH. Survival Trend of Tuberculosis patients and risk factors Associated with Mortality and developing drug-resistant tuberculosis in Hospital Pulau Pinang. Malaysia: A Retrospective Study; 2022. pp. 467\u201382."},{"key":"6808_CR5","unstructured":"World Health Organization. Tuberculosis Report, vol. XLIX, no. 9-10-11. 2020."},{"key":"6808_CR6","unstructured":"I. Odo AB, Obeagu M, Ochei EI, Nkombe KC, Olusola-Falae E, Effa B. E, Intensified TB Case finding in PMTCT settings in Nigeria should be reconsidered. Int. J. Adv. Res. Biol. Sci. 2016;3(2):85\u201392, vol. 3, no. 2, p. 2016, 2016."},{"key":"6808_CR7","unstructured":"Igwe OO, Obeagu CM. IE, Clinical characteristics of people living with HIV\/AIDS on ART in 2014 at tertiary health institutions in Enugu, Nigeria. J Pub Health Nutri. 2022; 5 (6). 2022;130.links\/645a166f5762c95ac3817d32\/Cli nical-characteristics-of-people-living-with-HIV- AIDS-on, vol. 5, no. 6, p. 5762, 2022."},{"key":"6808_CR8","doi-asserted-by":"publisher","DOI":"10.22192\/ijarbs","author":"EI Obeagu","year":"2023","unstructured":"Obeagu EI, Onuoha EC. Tuberculosis among HIV patients: a review of Prevalence and Associated factors. No September. 2023. https:\/\/doi.org\/10.22192\/ijarbs.","journal-title":"No September"},{"key":"6808_CR9","doi-asserted-by":"publisher","unstructured":"Kwan CK, Ernst JD. HIV and Tuberculosis: a Deadly Human Syndemic, 24, 2, pp. 351\u201376, 2011, https:\/\/doi.org\/10.1128\/CMR.00042-10.","DOI":"10.1128\/CMR.00042-10"},{"key":"6808_CR10","unstructured":"Edoho SH, Obeagu GU. Under-nutrition among HIV-exposed uninfected children: a review of African perspective, 2, 3, pp. 120\u20137, 2022."},{"key":"6808_CR11","unstructured":"Madekwe CC, Madekwe CC. Inequality of monitoring in Human Immunodeficiency Virus, Tuberculosis and Malaria : A Review Inequality of monitoring in Human Immunodeficiency Virus, Tuberculosis and Malaria : A Review, no. September, 2022."},{"key":"6808_CR12","doi-asserted-by":"crossref","unstructured":"E. Ifeanyi and G. Uzoma, \u201cParameters of Pulmonary Tuberculosis Patients Co-infected with Human Immunodeficiency Virus on Chemotherapy. Studies on Some Cytokines, CD4, Hepcidin, Iron, and Some Haematological Parameters of Pulmonary Tuberculosis Patients Co-infected with Human Immunodeficiency Virus on Chemotherapy for 60 Days in Southeast, Nigeria,\u201d no. September, 2020, doi: 10.9734\/JPRI\/2020\/v32i2230767.","DOI":"10.9734\/jpri\/2020\/v32i2230767"},{"key":"6808_CR13","doi-asserted-by":"publisher","DOI":"10.22192\/ijamr","author":"EI Obeagu","year":"2023","unstructured":"Obeagu EI. Human immunodeficiency virus and tuberculosis infection: a review of prevalence of associated factors. No November. 2023. https:\/\/doi.org\/10.22192\/ijamr.","journal-title":"No November"},{"key":"6808_CR14","unstructured":"Ogbuabor AO, Analysis of the factors and predictors of adherence of people living with HIV \/. October, Aids in tertiary health institutions in enugu, no. 2022."},{"key":"6808_CR15","unstructured":"World Health Organization. Global tuberculosis report, 2013."},{"key":"6808_CR16","unstructured":"Federal Ministry of Health Ethiopia. National Consolidated Guidelines for Comprehensive Hiv Prevention, Care and, Fmoh, pp. 1\u2013238, 2018, [Online]. Available: file:\/\/\/C:\/Users\/Tere\/Desktop\/University of South Africa (17-2017)\/Documents on Cervical Cancer\/July 22,2017\/All Litratures\/National Comprehensive HIV Care Guideline 2018.pdf."},{"key":"6808_CR17","doi-asserted-by":"publisher","unstructured":"Dawit Z, Abebe S, Dessu S, Mesele M, Sahile S, Ajema D. Incidence and predictors of mortality among children co-infected with tuberculosis and human immunodeficiency virus at public hospitals in Southern Ethiopia, PLoS One, vol. 16, no. 6 June, pp. 1\u201314, 2021, https:\/\/doi.org\/10.1371\/journal.pone.0253449.","DOI":"10.1371\/journal.pone.0253449"},{"key":"6808_CR18","doi-asserted-by":"crossref","unstructured":"Kebede F, Kebede B, Kebede T, Agmasu M. Effect of Isoniazid Preventive Therapy on the Incidence of Tuberculosis among Seropositive Children Attending HIV \/ AIDS Care in Two General Hospitals, Northwest Ethiopia, 2021, vol. 2021, 2021.","DOI":"10.1155\/2021\/9996953"},{"key":"6808_CR19","doi-asserted-by":"publisher","unstructured":"Sterling TR, Pham PA, Chaisson RE. HIV infection \u2013 related tuberculosis: clinical manifestations and treatment, 50, no. Suppl 3, pp. 223\u201330, 2010, https:\/\/doi.org\/10.1086\/651495.","DOI":"10.1086\/651495"},{"issue":"1","key":"6808_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1756-0500-5-331","volume":"5","author":"Y Wondimeneh","year":"2012","unstructured":"Wondimeneh Y, Muluye D, Belyhun Y. Prevalence of Pulmonary Tuberculosis and immunological profile of HIV co-infected patients in Northwest Ethiopia. BMC Res Notes. 2012;5(1):1. https:\/\/doi.org\/10.1186\/1756-0500-5-331.","journal-title":"BMC Res Notes"},{"key":"6808_CR21","doi-asserted-by":"publisher","unstructured":"Abrha H, Tsehayneh B, Massa D, Tesfay A, Kahsay H. Survival Experience and its Predictors among TB \/ HIV Co-infected Patients in Epidemiology: Open Access Survival Experience and its Predictors among TB \/ HIV Co-infected Patients in Southwest Ethiopia, no. January 2015, 2016, https:\/\/doi.org\/10.4172\/2161-1165.1000191.","DOI":"10.4172\/2161-1165.1000191"},{"key":"6808_CR22","doi-asserted-by":"publisher","unstructured":"Huang Y, Hu Z. Lower mean corpuscular hemoglobin concentration is associated with poorer outcomes in intensive care unit admitted patients with acute myocardial infarction, 4, 5, pp. 1\u20138, 2016, https:\/\/doi.org\/10.21037\/atm.2016.03.42.","DOI":"10.21037\/atm.2016.03.42"},{"key":"6808_CR23","doi-asserted-by":"crossref","unstructured":"Abay F, Yalew A, Shibabaw A, Enawgaw B. Hematological Abnormalities of Pulmonary Tuberculosis Patients with and without HIV at the University of Gondar Hospital, Northwest Ethiopia : A Comparative Cross-Sectional Study, vol. 2018, pp. 1\u20137, 2018.","DOI":"10.1155\/2018\/5740951"},{"issue":"1","key":"6808_CR24","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.hemonc.2017.05.029","volume":"11","author":"J Pengon","year":"2018","unstructured":"Pengon J, Svasti S, Kamchonwongpaisan S. Hematological parameters and red blood cell morphological abnormality of glucose-6-Phosphate dehydrogenase deficiency co-inherited with thalassemia. Hematol Oncol Stem Cell Ther. 2018;11(1):18\u201324. https:\/\/doi.org\/10.1016\/j.hemonc.2017.05.029.","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"6808_CR25","doi-asserted-by":"crossref","unstructured":"Chaloemwong J, Tantiworawit A, Rattanathammethee T, Hantrakool S. Useful clinical features and hematological parameters for the diagnosis of dengue infection in patients with acute febrile illness: a retrospective study, pp. 1\u201310, 2018.","DOI":"10.1186\/s12878-018-0116-1"},{"key":"6808_CR26","unstructured":"Al Salhen KS, Mahmoud AY, City E. Hematological Profile of patients with type 2 Diabetic Mellitus in, 4, 2022."},{"key":"6808_CR27","doi-asserted-by":"crossref","unstructured":"Sharif A, Mude A. Exploring Hematological Parameters and Their Prognostic Value in Adult COVID-19 Patients: Insights from Mogadishu, Somalia, vol. 2023, 2023.","DOI":"10.1155\/2023\/8862457"},{"key":"6808_CR28","doi-asserted-by":"publisher","unstructured":"Waris A, et al. Evaluation of hematological parameters as an indicator of disease severity in Covid- \u00ad 19 patients: Pakistan \u2019 s experience. No April. 2021;1\u201310. https:\/\/doi.org\/10.1002\/jcla.23809.","DOI":"10.1002\/jcla.23809"},{"key":"6808_CR29","doi-asserted-by":"publisher","unstructured":"Kishimoto S, Maruhashi T, Kajikawa M, Matsui S. Hematocrit, hemoglobin and red blood cells are associated with vascular function and vascular structure in men. Sci Rep. 2020;1\u20139. https:\/\/doi.org\/10.1038\/s41598-020-68319-1.","DOI":"10.1038\/s41598-020-68319-1"},{"issue":"1","key":"6808_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1423-0127-16-102","volume":"16","author":"C Obirikorang","year":"2009","unstructured":"Obirikorang C, Yeboah FA. Blood haemoglobin measurement as a predictive indicator for the progression of HIV\/AIDS in resource-limited setting. J Biomed Sci. 2009;16(1):1\u20137. https:\/\/doi.org\/10.1186\/1423-0127-16-102.","journal-title":"J Biomed Sci"},{"key":"6808_CR31","doi-asserted-by":"publisher","unstructured":"Hickman DL, Putta S, Johnston NA, Prongay KD. Model Selection, Princ. Anim. Res. Grad. Undergrad. Students, vol. 2007, no. August, pp. 93\u2013116, 2017, https:\/\/doi.org\/10.1016\/B978-0-12-802151-4.00006-2.","DOI":"10.1016\/B978-0-12-802151-4.00006-2"},{"key":"6808_CR32","doi-asserted-by":"publisher","unstructured":"Beletew B, Mengesha A, Ahmed M, Fitwi A, Wudu M. Determinants of Anemia among HIV-Positive children on highly active antiretroviral therapy attending hospitals of North Wollo Zone, Amhara Region, Ethiopia, 2019: a case-control study. Anemia. 2020;2020. https:\/\/doi.org\/10.1155\/2020\/3720572.","DOI":"10.1155\/2020\/3720572"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-024-06808-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13104-024-06808-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-024-06808-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T09:08:30Z","timestamp":1717232910000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-024-06808-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,1]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["6808"],"URL":"https:\/\/doi.org\/10.1186\/s13104-024-06808-6","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,1]]},"assertion":[{"value":"10 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"A statement to confirm that all methods were performed in accordance with the ethical standards as laid down in the declaration of Helsinki and its later amendments or comparable ethical standards. Hence, an informed consent was not obtained from participants, as the data was secondary source and the Bahir Dar University research technical and ethical review board waived this informed consent with Ref.no Stat-S\/166\/2014 E.C because, secondary source of data. Then, the present study was approved by Bahir Dar University research technical and ethical review board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Author declared that there was not a conflict of interest between authors or between author and institutions.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"150"}}